← Back to Patent Explorer
US3903266A Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions and methods for disaggregating blood cells

Assignee: Individual
•
Filing: 1974-09-24
•
Granted: 1975-09-02
•
Expires: 1994-09-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methoxylated flavonoids having at least two methoxyl radicals or substituents exhibit powerful anti-adhesive effects on blood cells in vivo and in vitro. When such flavonoids are combined with an anticoagulant, greater protection against thrombi formation is provided than when either is used without the other.

Inventors

  • 👤 Ralph C Robbins

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 16:33
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61K31/33; A61K31/335; A61K31/35

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 22 words
A COMPOSITION FOR DISAGGREGATING BLOOD CELLS AND INHIBITING BLOOD COAGULATION COMPRISING A FLAVONOID HAVING AT LEAST TWO METHOXYL SUBSTITUENTS AND AN ANTICOAGULANT.
Claim 2
Dependent Claim 22 words
A COMPOSITION FOR DISAGGREGATING BLOOD CELLS AND INHIBITING BLOOD COAGULATION COMPRISING A FLAVONOID HAVING AT LEAST TWO METHOXYL SUBSTITUENTS AND AN ANTICOAGULANT.
Claim 3
Dependent Claim 20 words
The composition as defined in claim 1 wherein said flavonoid is 3'', 4'', 5, 6, 7, 8 - hexamethoxyflavone (Nobiletin).
Claim 4
Dependent Claim 12 words
The composition as defined in claim 1 wherein said anticoagulant is Heparin.
Claim 5
Dependent Claim 25 words
The composition as defined in claim 1 wherein said flavonoid is 3'', 4'', 5, 6, 7, 8 - hexamethoxyflavone (Nobiletin) and said anticoagulant is Heparin.
Claim 6
Independent Claim 26 words
A method of disaggregating blood cells and inhibiting blood coagulation comprising infusion into the bloodstream a flavonoid having at least two methoxyl substituents and an anticoagulant.
Claim 7
Independent Claim 26 words
A method of disaggregating blood cells and inhibiting blood coagulation comprising infusion into the bloodstream a flavonoid having at least two methoxyl substituents and an anticoagulant.
Claim 8
Dependent Claim 20 words
The method as defined in claim 5 wherein said flavonoid is 3'', 4'', 5, 6, 7, 8 - hexamethoxyflavone (Nobiletin).
Claim 9
Dependent Claim 12 words
The method as defined in claim 5 wherein said anticoagulant is Heparin.
Claim 10
Dependent Claim 25 words
The method as defined in claim 5 wherein said flavonoid is 3'', 4'', 5, 6, 7, 8 - hexamethoxyflavone (Nobiletin) and said anticoagulant is Heparin.

References Cited (Backward Citations)

US2543674A Cited
US3247063A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-09-01 1979-03-03 1979-09-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-09-01 1983-03-03 1983-09-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-09-01 1987-03-03 1987-09-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag